Inventor
NEUSTADT BERNARD R
US76 patents
⚠️ This page may combine multiple inventors who share the name “NEUSTADT BERNARD R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
49 patentsUS6329395B1Dec 11, 2001
Neuropeptide Y5 receptor antagonists
SCHERING CORP186 citations99
US4929641AMay 29, 1990
Mercapto-acylamino acid antihypertensives
SCHERING CORP164 citations99
US4587258AMay 6, 1986
Angiotensin-converting enzyme inhibitors
SCHERING CORP197 citations99
US6689765B2Feb 10, 2004
Piperazine derivatives useful as CCR5 antagonists
SCHERING CORP71 citations97
US6391865B1May 21, 2002
Piperazine derivatives useful as CCR5 antagonists
SCHERING CORP94 citations97
US6387930B1May 14, 2002
Piperidine derivatives useful as CCR5 antagonists
SCHERING CORP76 citations96
US4818749AApr 4, 1989
Carboxyalkyl dipeptides and medical use thereof in treating hypertension and congestive heart failure
SCHERING CORP73 citations96
US4808573AFeb 28, 1989
Carboxyalkyl dipeptides and anti-hypertensive use thereof
SCHERING CORP71 citations96
US6630475B2Oct 7, 2003
Adenosine A2a receptor antagonists
SCHERING CORP53 citations95
US5393755AFeb 28, 1995
Polycyclic guanine derivatives
SCHERING CORP117 citations94
US6204282B1Mar 20, 2001
Benzimidazole compounds that are vitronectin receptor antagonists
SCHERING CORP22 citations93
US5262436ANov 16, 1993
Acylamino acid antihypertensives in the treatment of congestive heart failure
SCHERING CORP23 citations93
US5232920AAug 3, 1993
N-(mercaptoalkyl)amides
SCHERING CORP24 citations93
US5208236AMay 4, 1993
N-(acylaminomethyl)glutaryl amino acids and use
SCHERING CORP38 citations93
US5075302ADec 24, 1991
Mercaptoacyl aminolactam endopeptidase inhibitors
SCHERING CORP37 citations93
US5061710AOct 29, 1991
Mercapto-acylamino acid antihypertensives
SCHERING CORP34 citations93
US4879309ANov 7, 1989
Mercapto-acylamino acids as antihypertensives
SCHERING CORP43 citations93
US4831157AMay 16, 1989
Preparation of angiotensin-converting enzyme inhibitors
SCHERING CORP24 citations93
US4801609AJan 31, 1989
Mercapto-acylamino acid antihypertensives
SCHERING CORP33 citations93
US4470972ASep 11, 1984
7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
SCHERING CORP46 citations93
US6897217B2May 24, 2005
2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
SCHERING CORP25 citations92
US6602885B2Aug 5, 2003
Piperidine derivatives useful as CCR5 antagonists
SCHERING CORP21 citations92
US5298492AMar 29, 1994
Diamino acid derivatives as antihypertensives
SCHERING CORP45 citations92
US6875772B2Apr 5, 2005
[1,2,4]-Triazole bicyclic adeonsine A2a receptor antagonists
SCHERING CORP16 citations84
US7041666B2May 9, 2006
Adenosine A2a receptor antagonists
SCHERING CORP13 citations83
US6228985B1May 8, 2001
Derivatives of aminobenzoic and aminobiphenylcarboxylic acids useful as anti-cancer agents
SCHERING CORP19 citations83
US4230635AOct 28, 1980
Substituted 4'-polyhaloisopropylsulfonanilides
SCHERING CORP22 citations82
US4199597AApr 22, 1980
Omega-(4-polyfluoro-2-hydroxy-2-propyl)-2,3,6-substituted-phenoxy and phenylthio)alkanoic acids and compounds related thereto
SCHERING CORP22 citations82
US4093742AJun 6, 1978
Anti-hypertensive polyhaloisopropyl-substituted arylureas
SCHERING CORP20 citations82
US7078408B2Jul 18, 2006
[1,2,4]-Triazole bicyclic adenosine A2a receptor antagonists
SCHERING CORP6 citations74
US5348944ASep 20, 1994
Carboxyalkyl dipeptides
SCHERING CORP9 citations74
US4511569AApr 16, 1985
Tricyclic lactams and derivatives useful in increasing cardiac contractility
SCHERING CORP10 citations74
US4379166AApr 5, 1983
Arylmethoxy-, arylmethylthio-, heteroarylmethoxy-, and heteroarylmethylthio-alkylaminoalcohols
SCHERING CORP16 citations74
US4267193AMay 12, 1981
N-substituted-4-(polyfluoro-2-hydroxy-2-propyl)anilines and compounds related thereto
SCHERING CORP13 citations74
US4081547AMar 28, 1978
Para-polyfluoroisopropyl-anilino-2-oxazoline compounds, pharmaceutical compositions and method of treating hypertension
SCHERING CORP4 citations74
US4058612ANov 15, 1977
6-(Polyhaloisopropyl)quinazoline-2,4-diones
SCHERING CORP12 citations74
US7384944B2Jun 10, 2008
Piperazine derivatives useful as CCR5 antagonists
SCHERING CORP6 citations73
US6897216B2May 24, 2005
Adenosine A2a receptor antagonists
SCHERING CORP5 citations73
US4840772AJun 20, 1989
Antiglaucoma compositions and methods
SCHERING CORP7 citations73
US4783444ANov 8, 1988
Antiglaucoma compositions and methods
SCHERING CORP12 citations73
US4584285AApr 22, 1986
Antihypertensive agents
SCHERING CORP15 citations73
US4616012AOct 7, 1986
Carboxyalkyl dipeptides as antiglaucoma agents
SCHERING CORP20 citations72
US4559340ADec 17, 1985
Antihypertensive agents
SCHERING CORP14 citations72
US7067655B2Jun 27, 2006
Adenosine A2a receptor antagonists
SCHERING CORP4 citations71
US5356925AOct 18, 1994
N-(mercaptoalkyl)ureas and carbamates
SCHERING CORP9 citations70
US5173506ADec 22, 1992
N-(mercaptoalkyl)ureas and carbamates
SCHERING CORP14 citations70
US4103018AJul 25, 1978
2-[4-(Polyhalo-2-hydroxy-2-propyl)anilino]-2-oxazolin-4-ones and thiazolin-4-ones corresponding thereto
SCHERING CORP8 citations68
US5407960AApr 18, 1995
Mercaptocycloacyl aminoacid endopeptidase inhibitors
SCHERING CORP2 citations63
US5389610AFeb 14, 1995
Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors
SCHERING CORP5 citations63
NEELAMKAVIL SANTHOSH FRANCIS
1 patentShowing the top 50 of 76 patents by PatentIndex Score.